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Abstract
Background: Vitamin D deficiency increases the risk of developing multiple sclerosis (MS) but it is unclear whether
vitamin D supplementation improves the clinical course of MS, and there is uncertainty about the dose and form of
vitamin D (D2 or D3) to be used. The mechanisms underlying the effects of vitamin D in MS are not clear. Vitamin D3
increases the rate of differentiation of primary oligodendrocyte precursor cells (OPCs), suggesting that it might help
remyelination in addition to modulating the immune response. Here we analyzed the transcriptome of differentiating
rat CG4 OPCs treated with vitamin D2 or with vitamin D3 at 24 h and 72 h following onset of differentiation.
Methods: Gene expression in differentiating CG4 cells in response to vitamin D2 or D3 was quantified using Agilent
DNA microarrays (n = 4 replicates), and the transcriptome data were processed and analysed using the R software
environment. Differential expression between the experimental conditions was determined using LIMMA, applying the
Benjamini and Hochberg multiple testing correction to p-values, and significant genes were grouped into co-
expression clusters by hierarchical clustering. The functional significance of gene groups was explored by pathway
enrichment analysis using the clusterProfiler package.
Results: Differentiation alone changed the expression of about 10% of the genes at 72 h compared to 24 h. Vitamin
D2 and D3 exerted different effects on gene expression, with D3 influencing 1272 genes and D2 574 at 24 h. The
expression of the vast majority of these genes was either not changed in differentiating cells not exposed to vitamin D
or followed the same trajectory as the latter. D3-repressed genes were enriched for Gene Ontology (GO) categories
including transcription factors and the Notch pathway, while D3-induced genes were enriched for the Ras pathway.
Conclusions: This study shows that vitamin D3, compared with D2, changes the expression of a larger number of genes
in OLs. Identification of genes affected by D3 in OLs should help to identify mechanisms mediating its action in MS.
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Background
There is evidence that vitamin D deficiency is associated
with increased risk of developing multiple sclerosis (MS)
and with an increased rate of disease progression (Hayes
& Nashold, 2018; Sintzel et al., 2018). However, the
therapeutic efficacy of vitamin D supplementation in MS
patients is still an open question, and interventional trials
have reported inconclusive results (Jagannath et al., 2018).
Vitamin D is produced in the skin by the action of
ultraviolet light. After two successive hydroxylations, the
1,25(OH)D active form binds to the intracellular vitamin
D receptor (VDR) and, in complex with the retinoid X
receptor (RXR), regulates hundreds of genes through the
vitamin D response element (VDRE) (Hayes & Nashold,
2018; Bikle, 2014).
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Vitamin D can also be assimilated from the diet or
as a supplement. Both the plant/fungus-derived vita-
min D2, ergocalciferol, and the animal-derived D3
form, cholecalciferol, are available as nutritional sup-
plements; both can be hydroxylated into their active
forms and bind VDR with similar affinity (Hollis,
1984), but there are differences in their catabolism
and in their binding affinity to vitamin D binding
protein (DBP), the major vitamin D transport protein
in blood, with vitamin D2 binding DBP with lower
affinity and being catabolised more quickly (Hayes &
Nashold, 2018; Bikle, 2014).
Studies comparing vitamin D2 and D3 for their ability
to raise and maintain circulating levels of 25(OH) D, the
serum marker of systemic vitamin D levels, have shown
that vitamin D2 is less effective than D3 when given as
single bolus (Tripkovic et al., 2012); however, results fol-
lowing daily administration of D2 or D3 are controver-
sial, with clinical trials showing higher efficacy of D3
(Zittermann et al., 2014; Tripkovic et al., 2017) or
equal efficacy (Holick et al., 2008). In a recent meta-
analysis, vitamin D2 and D3 were found equally ef-
fective in raising vitamin D levels in infants
(Zittermann et al., 2020). It has been suggested that
vitamin D2 supplementation reduces circulating vita-
min D3 levels; however, a recent randomized con-
trolled trial showed that the reciprocal is also true
(Hammami et al., 2019). The general consensus is
that vitamin D3 is the preferred form to be adminis-
tered (Jagannath et al., 2018), but few studies have
compared D2 and D3 in terms of their direct cellular
effects under controlled conditions.
The mechanisms mediating the protective action of
vitamin D in MS are not fully characterized. In
addition to regulating calcium homeostasis, vitamin D
is immunomodulatory and anti-inflammatory (Hayes
& Nashold, 2018; Sintzel et al., 2018; Mora et al.,
2008). In the last twenty years, many studies have re-
ported effects on the brain; vitamin D inhibits neuro-
inflammation, is neuroprotective and neurotrophic
(Hayes & Nashold, 2018; Garcion et al., 2002; Eyles
et al., 2013; Cui et al., 2015). VDR is present in neu-
rons and glial cells (Baas et al., 2000; Eyles et al.,
2005). Vitamin D acts directly on brain cells by pro-
moting the differentiation of neural stem cells (NSCs)
into neurons and oligodendrocytes (OLs), and indu-
cing the expression of growth factors, such as nerve
growth factor (Ngf), in neurons and OLs (Baas et al.,
2000; Shirazi et al., 2015). The regenerative and
neurotrophic effects of vitamin D, together with the
presence of VDR in OLs, suggest that it might have a
myelinating action, which might contribute to its pro-
tective effects in MS. In this respect, de la Fuente
et al. found that vitamin D increased the
differentiation and maturation of primary oligo-
dendrocyte progenitor cells (OPCs) (de la Fuente
et al., 2015).
Rat central glia-4 (CG4) OPCs are considered a good
model of myelination in vitro; the cells are maintained at
the precursor stage by culture with growth factors (GFs),
and can be differentiated into OLs by withdrawal of GFs
and culture in differentiation medium (DM) (Louis
et al., 1992; Stariha & Kim, 2001; Gyetvai et al., 2017).
Interestingly, Baas et al. found that CG4 cells ex-
press VDR, as primary OPCs, and respond to vita-
min D by increasing expression of VDR and of Ngf;
however, an effect on myelin proteins was not found,
leading to the conclusion that vitamin D does not
positively affect the differentiation of these cells
(Baas et al., 2000).
To better understand the molecular mechanisms by
which vitamin D acts on OLs, we analyzed the gene ex-
pression profile of rat CG4 OPCs in response to vitamin
D, and compared vitamin D2 with D3.
Methods
Cell culture
The rat CG4 OPCs, originally obtained from primary
cultures of bipotential oligodendrocyte-type-2-astro-
cytes (O-2A) (Louis et al., 1992), were cultured as
previously reported (Gyetvai et al., 2017; Cervellini
et al., 2013). CG4 cells are maintained at the precur-
sor stage by culture in growth medium (GM), con-
sisting of Dulbecco’s modified Eagle medium
(DMEM; Sigma-Aldrich) supplemented with biotin
(10 ng/ml), basic fibroblast growth factor (bFGF; 5
ng/ml), platelet-derived growth factor (PDGF; 1 ng/
ml), N1 supplement (all from Sigma-Aldrich) and
30% B104-conditioned medium, obtained as previ-
ously reported (Cervellini et al., 2013). The cells can
be differentiated into mature OLs by withdrawal of
growth factors (bFGF and PDGF) and of B104-
conditioned medium and culture in DM, consisting
of DMEM-F12 (Invitrogen) supplemented with pro-
gesterone (3 ng/ml), putrescine (5 μg/ml), sodium sel-
enite (4 ng/ml), insulin (12.5 μg/ml), transferrin
(50 μg/ml), biotin (10 ng/ml), thyroxine (0.4 μg/ml)
and glucose (3 g/l) (all from Sigma-Aldrich).
Cells were plated in poly-L-ornithine-coated 12-well
plates (100,000 cells in 2 ml GM per well). After over-
night culture, the cells were induced to differentiate by
switching to DM. Cells were cultured for the indicated
times; half of the medium was changed every other day.
For vitamin D treatment, vitamin D2 (1,25-dihydroxyvi-
tamin D2; Cayman Chemical) or vitamin D3 (1,25-dihy-
droxyvitamin D3; Sigma-Aldrich) were dissolved in
ethanol (96%; Sigma-Aldrich) at 100 μM and then
Mengozzi et al. Molecular Medicine           (2020) 26:32 Page 2 of 11
diluted in medium at the final concentration (100 nM).
Vehicle (ethanol 0.1%) was added to untreated cells.
RNA extraction
Each sample was lysed with 1ml of QIAzol (QIAGEN).
Total RNA was extracted using the miRNeasy system and
protocol (QIAGEN). RNA concentration, purity and in-
tegrity were determined using a NanoDrop 1C (NanoDrop
Technologies) spectrophotometer and an Agilent 4200
TapeStation (Agilent Technologies). All samples had a
A260/A280 ratio > 1.9 and RNA Integrity Number > 8.2.
RT-qPCR
Reverse transcription (RT) and real time quantitative
PCR (qPCR) were carried out as reported (Gyetvai et al.,
2017), using TaqMan® gene expression assays (Applied
Biosystems/Thermo Fisher Scientific). Results were nor-
malized to Hprt1 expression (reference gene) and
expressed as fold change (FC) versus one of the control
samples (as indicated), chosen as the calibrator. The
Taqman® assays used were: Rn00569647_m1 (Jag1);
Rn00586568_m1 (Dll3); Rn00569763_m1 (Psen1);
Rn01508945_g1 (Rras2); Rn01533872_m1 (Ngf);
Rn00676060_m1 (Tgfb2); Rn01450612_s1 (Sox4);
Rn00690431_m1 (Tfeb); Rn00690616_m1 (VDR);
Rn01527840_m1 (Hprt1).
Microarrays
Biological quadruplicate samples were analyzed for each
treatment group. In total, 24 arrays were analyzed: 4 un-
treated, 4 vitamin D2 and 4 vitamin D3 at each time point
(following, respectively, 24 h and 72 h of treatment). Total
RNA (200 ng) was amplified by in vitro transcription using
the Low Input Quick Amp One color kit, incorporating
Cy3-labelled CTP (Agilent Technologies), and hybridized
onto SurePrint G3 Rat GE 8 × 60 K Microarrays v2 (AMA-
DID 074036; Agilent Technologies) for 16–20 h at 65 °C
in an Agilent oven with rotisserie. Following hybridization,
the arrays were washed and scanned to derive the array
images, using an Agilent microarray scanner G2505C.
Feature Extraction Software (v11.5; Agilent) was used to
generate the array data from the images, using Agilent
grid 074036_D_F_20181024.
Microarray data analysis
Data analysis was performed in R (Team, 2014) using
the LIMMA package (Ritchie et al., 2015). Grid annota-
tion for the AMADID 074036 microarray was down-
loaded from Agilent eArray, and gene annotations were
obtained from the Rattus.norvegicus R package based on
the rn5 genome build (Team, 2015). Microarray data
were background corrected using the “normexp” method
(with an offset of 50) and quantile normalized, produ-
cing normalized expression values in the log base 2
scale. Data were then filtered to remove all control
probes, and non-control probes exhibiting low signals
across the array sets. Keeping only those non-control
probes that were at least 10% brighter than negative con-
trol probe signals on at least four arrays (based on the
existence of four replicates per condition) left 31,691 out
of 62,976 probes. Data from identical replicate probes
within the same array were then averaged to produce ex-
pression values at the unique probe level, obtaining 20,
326 unique probes, of which 15,247 are assigned to gen-
ome features with an Entrez gene identifier (Entrez ID).
Testing for differential expression between the ex-
perimental conditions was performed in LIMMA
using linear modeling. Significance p-values were
corrected for multiplicity using the Benjamini and
Hochberg (BH) method, obtaining adjusted p-values
(adj. P.Val). All the 20,326 unique probes were sub-
jected to differential expression analysis but only the
data for the significantly differentially expressed
probes mapping to an Entrez ID (5565) are reported
in Additional File 1 and were considered in the
downstream analyses.
Hierarchical clustering was performed by complete
linkage clustering and using the Pearson correlation for
the distance metric. Abundance values for each probe
were transformed to z-scores for clustering. Functional
enrichment analysis was performed using the R package
clusterProfiler (version 3.8.1) (Yu et al., 2012). The soft-
ware produces adjusted p-values (p.adjust) using the BH
correction method.
Results
Set up and experimental treatment
We first established the appropriate experimental condi-
tions for studying the effect of vitamin D on the gene ex-
pression profile of differentiating CG4 cells. In a
previous study, Baas et al. found that VDR is present in
CG4 OPCs and its levels are increased 2-fold after cul-
ture for two days in differentiating conditions (Baas
et al., 2000); we therefore hypothesized that a pre-
incubation in DM for two days before treatment with
vitamin D might increase the basal levels of VDR and
the response to vitamin D. Since VDR is induced by vita-
min D3 (Baas et al., 2000), we monitored basal and vita-
min D3-induced VDR levels in different culture
conditions. The dose of 100 nM vitamin D3 was chosen
based on previous studies (Baas et al., 2000; de la Fuente
et al., 2015), having verified that a higher dose of D3
(200 nM) did not induce higher levels of VDR expression
compared to D3 100 nM, as assessed at 72 h of D3 treat-
ment (FC vs control, mean ± SD, N = 3; D3 at 100 nM:
2.3 ± 0.2; D3 at 200 nM: 2.0 ± 0.3).
Cells were plated, left to adhere overnight, then
medium was changed to DM and cells were treated
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with vitamin D3 added at the same time as DM
(Fig. 1a) or after pre-incubation in DM for 48 h (Fig.
1b). VDR mRNA was measured after 24 h or 72 h of
incubation with vitamin D3 in both conditions. A 48-
h pre-incubation in DM increased basal levels of VDR
and vitamin D3-induced VDR levels at 24 h and 72 h
(Fig. 1). Of note, VDR expression was induced by
vitamin D3 at 24 h only after cells were pre-
differentiated for 48 h (Fig. 1b, left panel). At this
time point, vitamin D2 at the same dose (100 nM) in-
duced similar levels of VDR as D3 (FC vs control,
mean ± SD, N = 3; D3: 2.8 ± 1.2; D2: 2.5 ± 0.7). There-
fore, the experimental design in Fig. 1b was used for
the transcriptome analysis, with vitamin D2 and D3
both used at 100 nM.
After 48 h of pre-differentiation in DM, cells were
treated with either vitamin D2 or D3; RNA was isolated
following incubation for a further 24 h and 72 h and ana-
lyzed using whole genome DNA microarrays. The DNA
microarray design uses unique oligonucleotide probes to
quantify the abundance of gene transcripts containing
the complementary sequences, and can include more
than one probe per gene. In the presentation of the re-
sults below we make the distinction between probes and
genes when necessary, and occasionally use the term
“probes-genes” when no distinction is required.
Fig. 1 Experimental design of cell differentiation and treatment with vitamin D3. Cells were plated and cultured overnight before
switching to DM. Vitamin D3 (Vit D3, 100 nM) or vehicle (control; Ctr) was added simultaneously with DM (a) or after 48 h (b). VDR gene
expression was measured by RT-qPCR 24 h or 72 h after vitamin D3 or vehicle addition. Data are expressed as fold change (FC) versus
Ctr1 and are the mean ± SD of four replicates. *** P < 0.001, **** P < 0.0001 by Student’s t-test. QPCR analysis was not conducted on
D2-treated cultures
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Effect of vitamin D2 and D3 on gene expression profile
Overall, addition of either vitamin D2 or D3 to differen-
tiating cells significantly affected gene expression, an ef-
fect that was more marked at 72 h (Fig. 2). Out of 15,247
probes, corresponding to 12,261 genes (ArrayExpress
Accession number E-MTAB-8098) about 30% were af-
fected by either vitamin D2 or D3 at 72 h, and 10% at
24 h (Fig. 2a).
The numbers of probes-genes affected by vitamin D2 and
D3 were broadly similar at 72 h, with most differentially
expressed genes regulated by both D2 and D3 (Fig. 2a, b).
However, the shorter-term response at 24 h showed a more
pronounced response to vitamin D3, with notably larger
numbers of probes-genes down-regulated compared with
vitamin D2 (721 versus 147 probes, corresponding to 664
versus 139 genes respectively; Fig. 2a). At 24 h, most genes
regulated by D2 were also regulated by D3, with some other
genes regulated by D3 only (Fig. 2b).
To visualize the global effect of vitamin D2 and D3 in re-
lation to untreated cells, we performed a hierarchical clus-
ter analysis of the 5565 probes differentially regulated when
comparing vitamin D2 or D3 with their respective controls
at both time points, as well as untreated controls at 72 h
versus 24 h. The results are shown as a heatmap in Fig. 2c.
By comparing untreated control cells (Ctrl) at 72 h
with Ctrl at 24 h, we can see that differentiation alone
noticeably affects gene expression. The actual number of
probes-genes regulated in Ctrl 72 h versus Ctrl 24 h is
reported in Fig. 2a. Figure 2c also shows that a number
of genes with low expression in control cells are up-
regulated by both vitamin D2 and D3 at 24 h, an effect
even more marked than that of differentiation at 72 h
(e.g. cluster 5 in Fig. 2c). Likewise, some of the genes
that have a high expression in 24 h Ctrl cells seem to be
down-regulated by vitamin D2 and D3 at 24 h, an effect
similar to differentiation alone (e.g. cluster 9 in Fig. 2c).
This trend is confirmed at 72 h, where vitamin D2 and
D3 have a more marked effect than at 24 h.
Effect of differentiation
To analyze the effect of vitamin D in relation to the ef-
fect of differentiation, we focused on the genes changed
Fig. 2 Probes-genes regulated by vitamin D2, vitamin D3 or differentiation alone at 24 and 72 h. (a) Values represent numbers of probes
detecting differentially expressed genes compared with their respective control (adj. P. Val≤ 0.05, testing significance relative to a 10%-fold
change in expression using LIMMA TREAT (McCarthy & Smyth, 2009)). The Venn diagrams (b) show the number of probes specifically down-
regulated (left) or up-regulated (right) by each vitamin or both. The control (Ctrl) 72 h vs Ctrl 24 h data is not represented in the Venn diagrams.
(c) Hierarchical cluster analysis and heatmap of all the probes significantly different in any of the comparisons listed in panel a (5,565 probes). All
the probes-genes are listed in Additional File 1, where information about the respective clusters is included
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by culture in DM alone. As reported in Fig. 2a, 837
probes (767 genes) were down-regulated and 827 (763
genes) were up-regulated in untreated cells (Ctrl) at 72 h
compared to Ctrl at 24 h.
The functional enrichment analysis of the 767
down-regulated and of the 763 up-regulated genes in
the 72 h versus 24 h control cells is reported in Fig. 3a.
This reveals that most of the down-regulated genes
were associated with the cell cycle and the up-
regulated genes were significantly (p.adjust ≤0.05)
enriched for Gene Ontology Biological Process (GO-
BP) categories including “cell maturation” (p.adjust
7.77E-03), “axon ensheathment” (p.adjust 2.28E-03),
“myelination” (p.adjust 6.75E-03); this is consistent
with the fact that CG4 cells in DM differentiate over
time (Gyetvai et al., 2017; Cervellini et al., 2013).
To visualize the effect of vitamin D2 and D3 at 24 h
on the genes down-regulated or up-regulated by
differentiation alone (767 and 763 respectively, as men-
tioned above), we performed a hierarchical cluster ana-
lysis (Fig. 3b) of the expression abundance of the
corresponding probes (837 and 827 respectively) in un-
treated cells at 24 and 72 h (highlighting the effect of dif-
ferentiation alone) and in vitamin D2- and D3-treated
cells at 24 h (highlighting the effect of each vitamin, that
can be visually compared to the effect of differentiation
alone).
The clusters 1–4 in Fig. 3b comprise all the probes
corresponding to the genes increased by differenti-
ation alone. Both vitamins, and in particular vitamin
D3, preferentially increase the expression of these
genes at 24 h.
The same trend was confirmed for the down-
regulated genes (clusters 5–8 in Fig. 3b), where the
preferential downregulating effect of vitamin D3 com-
pared to D2 was more marked. Functional enrichment
Fig. 3 Effect of vitamin D2 and D3 on the genes regulated by differentiation: functional enrichment analysis. (a) The enriched Gene Ontology
Biological Processes (GO-BPs) among the 767 down-regulated (left) and 763 up-regulated (right) genes, shown in Fig. 2a as “Ctrl 72 vs Ctrl 24”, are
listed. The size of the dots is proportional to the number of genes and the color represents the corrected p-value (p.adjust), as indicated in the
legend. (b) Cluster analysis and heat map of the expression data for the probes corresponding to the genes in (a) (837 down-regulated and 827
up-regulated by differentiation alone, Fig. 2a); the expression signal at 24 h and 72 h in untreated cells and at 24 h in D2- and D3-treated cells is
shown, to visualize the effect of D2 and D3 versus their control at 24 h and the effect of differentiation alone at 72 h versus 24 h. (c) Enriched GO-
BP terms corresponding to some of the clusters. All the probes-genes included in the clusters and in the GO-BPs are listed in Additional File 2
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analysis of the down-regulated clusters 6 and 7 (Fig.
3c) identified GO-BP categories associated with cell
cycle, whereas “axon regeneration” (p.adjust 3.73E-02)
was one of the GO-BP terms significantly enriched
among the clusters increased by differentiation and by
vitamin D2 and D3 (cluster 3, Fig. 3c).
Analysis of vitamin D-regulated genes in relation to
differentiation
A more specific analysis of the effects of vitamin D
on gene expression in relation to the change in the
gene expression profile induced by differentiation
alone (Ctrl 72 h versus Ctrl 24 h) is shown in Fig. 4.
More than half of the genes up-regulated (in orange
in Fig. 4) at 24 h by vitamin D2 (a) or D3 (b) were
also induced by differentiation (in orange in the bot-
tom pie-charts of the two panels), with the remaining
genes (in grey in the bottom pie-charts of the panels)
not affected by differentiation alone. Only one gene
(spondin 1, Additional File 1) induced by vitamin D2
or D3 at 24 h was changed in the opposite direction
by differentiation.
Of the genes that were down-regulated at 24 h (in blue
in Fig. 4) by vitamin D2 (a) or D3 (b), most genes were
down-regulated (in blue in the bottom pie charts) or un-
affected (in grey in the bottom pie charts) by differenti-
ation. Only few vitamin D-down-regulated probes (six
for D2 and eleven for D3) were changed in the opposite
direction by differentiation (Additional File 1). In sum-
mary, a 24-h exposure to vitamin D had either a unique
Fig. 4 Genes regulated by D2 and D3 and relative effect of differentiation alone. The numbers of significant probes are indicated in each pie
chart. The top pie charts in all panels indicate the number of probes that are up- or down-regulated by vitamin D2 (a and c) or D3 (b and d)
compared to the control at the same time point (a and b, 24 h; c and d, 72 h). The bottom pie charts of all panels describe how these genes are
regulated by differentiation (defined by comparing Ctrl 72 h vs Ctrl 24 h). Differentially regulated genes were obtained according to the same
criteria described in the legend to Fig. 2a. All the probes-genes are included in Additional File 1, where the membership of the pie chart groups
is reported
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effect for specific genes or an effect on gene expression
similar to that of differentiation.
A similar analysis was performed at 72 h (Fig. 4c and
d). At this time point, the overlap between vitamin D-
and differentiation-regulated genes was smaller, and
most of the effect on the gene expression profile was
unique to vitamin D.
Genes uniquely regulated by vitamin D3 and not by D2
Because vitamin D3 had a more marked effect on gene ex-
pression at 24 h than D2 (Fig. 2a, Fig. 4a and b), we ana-
lyzed the genes uniquely regulated by D3 (but not by D2)
at 24 h and their behavior in relation to differentiation. As
shown in Fig. 5, all the genes uniquely regulated by vita-
min D3 were either not changed by differentiation in ab-
sence of vitamin D, or followed the same trajectory as
differentiation, with only five probes down-regulated by
D3 but up-regulated by differentiation.
Gene expression profile in oligodendrocyte cells is more
greatly affected by vitamin D3 than D2
To analyze the differential effect on gene expression of
vitamin D3 compared with D2, we focused on the
probes-genes uniquely regulated by vitamin D3 (and not
by vitamin D2) at 24 h. At this time point, vitamin D3
uniquely down-regulated 605 probes and up-regulated
240 probes, as shown in Fig. 5.
Functional enrichment analysis of the genes corre-
sponding to the probes significantly decreasing in
abundance after 24 h in response to either vitamin D2
(n = 147, Fig. 2a and 4a) or D3 (n = 721, Fig. 2a and
4b) and of those uniquely down-regulated by D3
(n = 605; Fig. 5) indicated that the two forms of vita-
min D produce notably different early effects on
oligodendrocyte cells (Additional File 3: Supplemen-
tary Fig. S1, Additional File 4). Interestingly, the 605
genes uniquely down-regulated by D3 at 24 h were
significantly enriched for GO terms associated with
transcription factor activity (“transcription factor com-
plex”, p.adjust 3.59E-03; “transcription factor activity”,
p.adjust 8.29E-04) suggesting that the two forms of
vitamin D might exert different effects on transcrip-
tional regulation by these complexes. Other functions
similarly and potentially more adversely affected by
D3 compared to D2 at 24 h included “RNA splicing”
(p.adjust 3.07E-02), “axonogenesis” (p.adjust 7.73E-03),
Toll-like receptor (TLR) cascade pathways (e.g. “TLR3
cascade”, p.adjust 4.01E-03), “MAPK signaling path-
ways” (p.adjust 2.25E-02) and “Notch signaling path-
way” (p.adjust 2.71E-02).
Functional enrichment analysis of the genes corre-
sponding to the probes significantly increased at 24 h by
vitamin D2 (n = 518, Fig. 2a and 4a) or D3 (n = 692; Fig.
2a and 4b) and of those uniquely up-regulated by D3
(n = 240, Fig. 5) is reported in Additional File 3: Supple-
mentary Fig. S2 and Additional File 4. The genes
uniquely up-regulated by D3 were enriched for the GO
term “GTP binding” (p.adjust 4.11E-02) whereas analysis
of all the genes up-regulated by vitamin D3 showed an
enrichment of the Ras signal transduction pathway (“Ras
protein signal transduction”, p.adjust 3.46E-02).
RT-qPCR validation
The significant expression changes observed in VDR and
in key genes of interest from the Notch (Jag1, Dll3,
Psen1) and Ras (RRas2, Ngf, Tgfb2) signaling pathways,
and in the transcription factors Sox4 and Tfeb, were
verified using RT-qPCR. Eight of the nine significant
changes investigated were successfully verified (Add-
itional File 5: Supplementary Table S1).
Discussion
The main finding of this study is that vitamin D2 and D3
exert markedly different effects on gene expression in dif-
ferentiating OPCs. Although there is some overlap in the
genes they regulate, D3 affects a larger repertoire of genes.
In particular, we identified some genes that are specifically
influenced by D3 only (Fig. 5 and Additional File 1), show-
ing that, in this experimental model, D2 and D3 (or their
respective derivatives) might behave as distinct molecular
entities with different biological activities.
In vivo, studies where D2 and D3 are compared are
likely to mainly reflect differences in their pharmacokin-
etics. This should not be an issue in an in vitro model
Fig. 5 Genes uniquely regulated by vitamin D3 at 24 h and relative
effect of differentiation alone. Numbers in the top pie charts refer to
probes up-regulated (orange) or down-regulated (blue) by D3 versus
control but not by D2 versus control. The list of the probes-genes is
reported in Additional File 1
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that should reflect the direct effect of the molecule
tested, and our results are likely to relate to differences
in the biological activity of the two forms of vitamin D.
Although, reportedly, vitamin D2 and D3 have similar
affinities for VDR (Bikle, 2014; Hollis, 1984), they may
have different affinity for other vitamin D binding pro-
teins. In fact, the action of vitamin D is mediated by
other receptors and binding proteins such as the
retinoid-related orphan receptors (RORs) and Erp57, a
membrane steroid-binding protein related to protein di-
sulfide isomerase (Khanal & Nemere, 2007; Nemere
et al., 2010; Slominski et al., 2017). These additional re-
ceptors may have important biological roles in the cen-
tral nervous system, and the protective effect of D3 on
axonal growth has been linked to activation of
membrane-associated rapid response steroid-binding re-
ceptor (MARRS)/Erp57 (Tohda et al., 2012).
Vitamin D3 and D2 both up-regulated VDR ex-
pression (Additional File 1), which was also up-
regulated during OPC differentiation, in agreement
with a previous report (Baas et al., 2000). Both vita-
mins regulated the expression of many genes that
were either not changed in differentiating cells not
exposed to vitamin D or followed the same trajec-
tory as the latter (Figs. 4 and 5); only very few genes
followed the opposite expression trajectory, suggest-
ing that in this system, as in primary OLs (de la
Fuente et al., 2015), vitamin D promotes rather than
antagonizing differentiation.
Although at 72 h both vitamin D2 and D3 had similar
effects on gene expression, at 24 h vitamin D3 was more
potent, changing the expression of a substantially higher
number of genes. The preferential action of D3 versus
D2 was particularly evident when considering the down-
regulated genes; only about one fourth of the genes
down-regulated by D3 were also down-regulated by D2
at 24 h, whereas most of the genes down-regulated by
D2 were also down-regulated by D3, as shown in Fig. 2.
The higher efficacy of vitamin D3 compared to D2 in in-
creasing myelination had been previously reported in a
rat model of peripheral nerve injury (Chabas et al.,
2013), but no studies had directly compared vitamin D2
and D3 in vitro on OL differentiation.
Functional enrichment analysis of the genes uniquely
down-regulated by D3 (unchanged by D2) at 24 h
highlighted an over-representation of the GO Molecular
Function (GO-MF) “transcription factor activity” (Add-
itional File 3: Supplementary Fig. S1); among these,
SRY-related HMG-Box Gene 4 (Sox4) and transcription
factor EB (Tfeb) (Additional File 4), whose high expres-
sion has been previously associated with inhibition of
myelination (Potzner et al., 2007; Meireles et al., 2018).
In addition, the KEGG MAPK signaling pathway was
overrepresented; of note, we previously reported that in
this model inhibition of ERK1/2 MAPK increases OL
differentiation (Gyetvai et al., 2017). Fibroblast growth
factor receptor 2 (Fgfr2) and platelet derived growth fac-
tor A (Pdgfa) were included in this pathway (Additional
File 4); since both Fgf and Pdgf are needed to maintain
CG4 OPCs in the undifferentiated state (Louis et al.,
1992; Gyetvai et al., 2017), inhibition of Fgfr and Pdgf
would promote differentiation.
Considering all the genes down-regulated by D3 at 24 h
(and therefore possibly also by D2), enrichment of the
Notch signaling pathway was identified (Additional File 3:
Supplementary Fig. S1). Activation of the Notch pathway
inhibits OPC differentiation during development and is in-
volved in the limited remyelination that characterizes MS
(Wang et al., 1998; John et al., 2002). Notch is a trans-
membrane receptor that is activated upon binding to sev-
eral ligands, including members of the Jagged and Delta-
like families; these ligands induce sequential cleavage of
Notch, with an essential cleavage performed by a gamma-
secretase, which contains presenilin (Hori et al., 2013).
The ligands Jagged 1 (Jag1) and delta-like canonical Notch
ligand 3 (Dll3) were inhibited by both vitamin D2 and D3
(Additional File 1). The inhibitory effect of vitamin D3 on
gamma-secretase activity had been previously reported in
the context of Alzheimer’s disease (Grimm et al., 2017); in
this respect, gamma-secretase, in addition to Notch, also
cleaves the amyloid precursor protein (APP) to produce
amyloid-beta. Inhibition of Notch ligands and of other
genes belonging to the Notch pathway (Additional File 4)
suggests a differentiating effect of vitamin D on these cells.
Interestingly, inhibition of Notch-signalling molecules,
which play a role in cancer stem cell maintenance, is one
of the mechanisms that mediate the anticancer properties
of vitamin D (So & Suh, 2015; Shan et al., 2017).
Functional enrichment analysis of all the genes up-
regulated by D3 revealed overrepresentation of the GO-
BP “Ras protein signal transduction” (Additional File 3:
Supplementary Fig. S2 and Additional File 4). GTPases
of the Ras family affect cell survival, proliferation and
differentiation (Crespo & Leon, 2000), and among these
Ras related 2 (Rras2) was recently found to be essential
for OL differentiation (Sanz-Rodriguez et al., 2018). In-
cluded in this pathway are also Ngf and transforming
growth factor beta 2 (Tgfb2), both reported to activate
Ras-dependent signalling pathways and to promote OPC
differentiation (Marei et al., 2013; Schmitz et al., 2010;
McKinnon et al., 1993; Palazuelos et al., 2014; Li et al.,
2017). Vitamin D3-induced upregulation of Ngf in these
cells was previously reported (Baas et al., 2000). Of note,
Rras2 and Ngf were also induced by D2, whereas Tgfb2
was uniquely induced by D3 (Additional File 4). Also in-
cluded in this pathway were several Rab genes, such as
Rab36, Rab9d, Rab6a, and Rab3d. Rab proteins, involved
in vesicular transport, are up-regulated during OL
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differentiation, in particular when OL start synthesizing
myelin (Bouverat et al., 2000); interestingly Rab6a and
Rab3d were uniquely up-regulated by D3 (GO-MF “GTP
binding”, Additional File 3: Supplementary Fig. S2;
Addition File 4). In addition, vitamin D3-induced tran-
scription factors (GO Cellular Component (GO-CC)
“nuclear transcription factor complex”, Additional File 3:
Supplementary Fig. S2, Additional File 4) included Sox2,
whose role in OL differentiation was recently reported
(Kuhbandner, 2018; Zhang et al., 2018) and CCAAT/en-
hancer binding protein beta (Cebpb), a VDR-responsive
gene that controls the differentiation of myeloid leukae-
mia cells (Marchwicka & Marcinkowska, 2018).
Although we did not observe any direct effect of vita-
min D on the expression of myelin genes, the induction
or repression effect of vitamin D, and in particular of
vitamin D3, on genes positively or negatively involved in
OL differentiation and myelination confirms the myeli-
nating effects of vitamin D in OLs that have been previ-
ously reported (de la Fuente et al., 2015; Gomez-Pinedo
et al., 2020). The lack of a direct effect of vitamin D on
the expression of myelin genes in these cells is in agree-
ment with previous studies (Baas et al., 2000) and high-
lights a limitation of this experimental model.
Conclusions
The identification of specific vitamin D3-regulated
genes in OPCs could provide important insights to
understand the mechanisms mediating the activity of
vitamin D in demyelinating disease and point to
mechanisms additional to those associated with im-
mune regulation, the latter being a major research
focus for the action of vitamin D in the context of
MS (Hayes & Nashold, 2018). However, to completely
understand the physiological relevance of our results,
our findings should be confirmed at the protein level
and in other experimental models, including in vivo
models of myelination.
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